219 related articles for article (PubMed ID: 26885263)
21. High expression of B7-H3 on stromal cells defines tumor and stromal compartments in epithelial ovarian cancer and is associated with limited immune activation.
MacGregor HL; Sayad A; Elia A; Wang BX; Katz SR; Shaw PA; Clarke BA; Crome SQ; Robert-Tissot C; Bernardini MQ; Nguyen LT; Ohashi PS
J Immunother Cancer; 2019 Dec; 7(1):357. PubMed ID: 31892360
[TBL] [Abstract][Full Text] [Related]
22. Cancer cell-expressed B7-H3 regulates the differentiation of tumor-associated macrophages in human colorectal carcinoma.
Mao Y; Chen L; Wang F; Zhu D; Ge X; Hua D; Sun J
Oncol Lett; 2017 Nov; 14(5):6177-6183. PubMed ID: 29113264
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of the induction of macrophage differentiation by the costimulatory molecule B7-H3 in human non-small cell lung cancer.
Sun J; Mao Y; Zhang YQ; Guo YD; Mu CY; Fu FQ; Zhang XG
Oncol Lett; 2013 Nov; 6(5):1253-1260. PubMed ID: 24179504
[TBL] [Abstract][Full Text] [Related]
24. High expression of B7-H3 and CD163 in cancer tissues indicates malignant clinicopathological status and poor prognosis of patients with urothelial cell carcinoma of the bladder.
Xu Z; Wang L; Tian J; Man H; Li P; Shan B
Oncol Lett; 2018 May; 15(5):6519-6526. PubMed ID: 29725402
[TBL] [Abstract][Full Text] [Related]
25. B7-H3 role in the immune landscape of cancer.
Castellanos JR; Purvis IJ; Labak CM; Guda MR; Tsung AJ; Velpula KK; Asuthkar S
Am J Clin Exp Immunol; 2017; 6(4):66-75. PubMed ID: 28695059
[TBL] [Abstract][Full Text] [Related]
26. B7-H3 promotes gastric cancer cell migration and invasion.
Li Y; Yang X; Wu Y; Zhao K; Ye Z; Zhu J; Xu X; Zhao X; Xing C
Oncotarget; 2017 Sep; 8(42):71725-71735. PubMed ID: 29069741
[TBL] [Abstract][Full Text] [Related]
27. B7-H3 regulates migration and invasion in salivary gland adenoid cystic carcinoma via the JAK2/STAT3 signaling pathway.
Fan TF; Deng WW; Bu LL; Wu TF; Zhang WF; Sun ZJ
Am J Transl Res; 2017; 9(3):1369-1380. PubMed ID: 28386362
[TBL] [Abstract][Full Text] [Related]
28. B7-H3 was highly expressed in human primary hepatocellular carcinoma and promoted tumor progression.
Wang F; Wang G; Liu T; Yu G; Zhang G; Luan X
Cancer Invest; 2014 Jul; 32(6):262-71. PubMed ID: 24787022
[TBL] [Abstract][Full Text] [Related]
29. Epidermal growth factor receptor and B7-H3 expression in esophageal squamous tissues correlate to patient prognosis.
Song J; Shi W; Zhang Y; Sun M; Liang X; Zheng S
Onco Targets Ther; 2016; 9():6257-6263. PubMed ID: 27785073
[TBL] [Abstract][Full Text] [Related]
30. B7-H3 Associates with IMPDH2 and Regulates Cancer Cell Survival.
Alhamad S; Elmasry Y; Uwagboe I; Chekmeneva E; Sands C; Cooper BW; Camuzeaux S; Salam A; Parsons M
Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444640
[TBL] [Abstract][Full Text] [Related]
31. ILT4 drives B7-H3 expression via PI3K/AKT/mTOR signalling and ILT4/B7-H3 co-expression correlates with poor prognosis in non-small cell lung cancer.
Zhang P; Yu S; Li H; Liu C; Li J; Lin W; Gao A; Wang L; Gao W; Sun Y
FEBS Lett; 2015 Aug; 589(17):2248-56. PubMed ID: 26149216
[TBL] [Abstract][Full Text] [Related]
32. B7-H3 silencing inhibits tumor progression of mantle cell lymphoma and enhances chemosensitivity.
Zhang W; Wang Y; Wang J; Dong F; Zhu M; Wan W; Li H; Wu F; Yan X; Ke X
Int J Oncol; 2015; 46(6):2562-72. PubMed ID: 25872657
[TBL] [Abstract][Full Text] [Related]
33. B7-H3 expression in breast cancer and upregulation of VEGF through gene silence.
Sun J; Guo YD; Li XN; Zhang YQ; Gu L; Wu PP; Bai GH; Xiao Y
Onco Targets Ther; 2014; 7():1979-86. PubMed ID: 25378933
[TBL] [Abstract][Full Text] [Related]
34. B7-H3 Immune Checkpoint Protein in Human Cancer.
Flem-Karlsen K; Fodstad Ø; Nunes-Xavier CE
Curr Med Chem; 2020; 27(24):4062-4086. PubMed ID: 31099317
[TBL] [Abstract][Full Text] [Related]
35. B7-H3 on circulating epithelial tumor cells correlates with the proliferation marker, Ki-67, and may be associated with the aggressiveness of tumors in breast cancer patients.
Pizon M; Schott DS; Pachmann U; Pachmann K
Int J Oncol; 2018 Nov; 53(5):2289-2299. PubMed ID: 30226585
[TBL] [Abstract][Full Text] [Related]
36. A Novel Anti-B7-H3 × Anti-CD3 Bispecific Antibody with Potent Antitumor Activity.
Feng Y; Xie K; Yin Y; Li B; Pi C; Xu X; Huang T; Zhang J; Wang B; Gu H; Fang J
Life (Basel); 2022 Jan; 12(2):. PubMed ID: 35207448
[TBL] [Abstract][Full Text] [Related]
37. Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC).
Carvajal-Hausdorf D; Altan M; Velcheti V; Gettinger SN; Herbst RS; Rimm DL; Schalper KA
J Immunother Cancer; 2019 Mar; 7(1):65. PubMed ID: 30850021
[TBL] [Abstract][Full Text] [Related]
38. B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes.
Altan M; Pelekanou V; Schalper KA; Toki M; Gaule P; Syrigos K; Herbst RS; Rimm DL
Clin Cancer Res; 2017 Sep; 23(17):5202-5209. PubMed ID: 28539467
[No Abstract] [Full Text] [Related]
39. Expression of CYP1B1 and B7-H3 significantly correlates with poor prognosis in colorectal cancer patients.
Liu X; Wang F; Wu J; Zhang T; Liu F; Mao Y; Hua D
Int J Clin Exp Pathol; 2018; 11(5):2654-2664. PubMed ID: 31938380
[TBL] [Abstract][Full Text] [Related]
40. Expression of B7-H3 in hypopharyngeal squamous cell carcinoma as a predictive indicator for tumor metastasis and prognosis.
Katayama A; Takahara M; Kishibe K; Nagato T; Kunibe I; Katada A; Hayashi T; Harabuchi Y
Int J Oncol; 2011 May; 38(5):1219-26. PubMed ID: 21344157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
